Mark N Prichard

Medimmune Vaccines, Inc.

$4,929,637

Attributed

$5,057,387

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2014–18

$2M$1.5M$1M$500K$0

'14

'15

'16

'17

'18

Funding mix

By agency

NIH$5,057,387 · 3

By mechanism

N01$2,907,905 · 1

N02$1,144,282 · 1

R44$749,700 · 1

R21$255,500 · 1

Top collaborators

Charles E Mckenna1 shared

Most similar at Medimmune Vaccines, Inc.

Same institution · by research overlap

Hong Jin$750,200
Shengqiang Li$8,290,368
Aurelia A Haller$750,000
George W Kemble$267,059

Others in their field

Top investigators on “Contracts”

David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Bambra Strokes · Ppd Development Lp$526,656,217
Mitchell J Malone · Texas A&M Research Foundation$320,373,312
Gary D Acton · University Of California-Davis$320,373,312

Research focus

ContractsViralVirus DevelopmentCell LineIn Vitro TestingMaintenanceTranslational ResearchVirologyMeetingsVirusTherapeutic DevelopmentScreeningAntiviral AgentsHerpesviridaeHerpesviridae VaccineIn VitroLive VaccineAdvanced DevelopmentCytomegalovirusPoxviridaeProgramsRecombinant VirusDisease /Disorder ModelDrug Screening /Evaluation